FindTrial
Sign In

Primary aldosteronism in diabetes and hypertension

Prevalence of primary aldosteronism in patients with type 2 diabetes mellitus and hypertension: Prospective study from western India

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/12/016785
Enrollment
1000
Registered
2018-12-26
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- patients with type 2 diabetes mellitus and hypertension

Interventions

None listed

Sponsors

Diamond Jubilee Society Trust Seth GSMC and KEM Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: History of type 2 diabetes BP 130/80 or on antihypertensives

Exclusion criteria

Exclusion criteria: Diabetic ketosis, hyperosmolar non-ketotic syndrome, active infections • heart failure (New York Heart Association class III or IV) • Pregnancy, breastfeeding, use of oral contraceptives, • known primary aldosteronism or a history of pheochromocytoma, Cushingâ??s syndrome, or hyperthyroidism • No consent

Design outcomes

Primary

MeasureTime frame
Prevalence of primary aldosteronism in patients with type 2 diabetes and hypertensionTimepoint: 18 months—

Secondary

MeasureTime frame
NilTimepoint: N/A—

Countries

India

Contacts

Public ContactDr Tushar Ramkrishna Bandgar

Seth G S Medical College and KEM Hospital

drtusharb@gmail.com9820025037

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026